Neumedicines

Neumedicines

Biotechnology, 133 N Altadena Dr, Pasadena, California, 91107, United States, 11-50 Employees

neumedicines.com

  • twitter
  • LinkedIn

phone no Phone Number: 62********

Who is NEUMEDICINES

Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical...

Read More

map
  • 133 N Altadena Dr, Pasadena, California, 91107, United States Headquarters: 133 N Altadena Dr, Pasadena, California, 91107, United States
  • 2003 Date Founded: 2003
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8733 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NEUMEDICINES

Neumedicines Org Chart and Mapping

Employees

David Morash

Member of Board of Directors

Rose Lopez

Sr. Director of Quality and Gmp Operations

Similar Companies to Neumedicines

Amgen

  • 10001+ 10001+
  • 1 Billion and Over $ 1 Billion and Over

Strateos

  • 51-200 51-200
  • 25 Million to 50 Million $ 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Neumedicines

Answer: Neumedicines's headquarters are located at 133 N Altadena Dr, Pasadena, California, 91107, United States

Answer: Neumedicines's phone number is 62********

Answer: Neumedicines's official website is https://neumedicines.com

Answer: Neumedicines's revenue is $5 Million to $10 Million

Answer: Neumedicines's SIC: 8733

Answer: Neumedicines's NAICS: 621511

Answer: Neumedicines has 11-50 employees

Answer: Neumedicines is in Biotechnology

Answer: Neumedicines top competitors include: Amgen , Strateos

Answer: Neumedicines contact info: Phone number: 62******** Website: https://neumedicines.com

Answer: Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and societal needs in the areas of oncology, hematology, and immunology. The company operates from its headquarters in Pasadena, California. Neumedicines' lead product candidate is recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine. rHuIL-12 is being developed under the trade name HemaMaxTM for various clinical indications, including hematopoietic syndrome of acute radiation syndrome (HSARS), skin cancers and other solid tumors, and blood disorders and malignancies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access